Jundishapur Journal of Microbiology

Published by: Kowsar

Classification of Pathogenic Bacteria in Cerebrospinal Fluid of Patients with Intracranial Infection After Neurosurgery and Selective Use of Antibacterial Agents

Yunxiang Chen 1 , Zhengyang Li 2 , Jihong Liu 1 , Yuejun Fan 1 , Minfeng Tong 1 , Jianglong Lu 3 and Gezhi Zhou 1 , *
Authors Information
1 Department of Neurosurgery, Jinhua Municipal Central Hospital, Jinhua 321000, Zhejiang Province, China
2 Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang Province, China
3 Department of Neurosurgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China
Article information
  • Jundishapur Journal of Microbiology: April 2018, 11 (4); e60788
  • Published Online: February 12, 2018
  • Article Type: Research Article
  • Received: August 23, 2017
  • Revised: January 17, 2018
  • Accepted: January 29, 2018
  • DOI: 10.5812/jjm.60788

To Cite: Chen Y, Li Z, Liu J, Fan Y, Tong M, et al. Classification of Pathogenic Bacteria in Cerebrospinal Fluid of Patients with Intracranial Infection After Neurosurgery and Selective Use of Antibacterial Agents, Jundishapur J Microbiol. 2018 ; 11(4):e60788. doi: 10.5812/jjm.60788.

Abstract
Copyright © 2018, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusions
Acknowledgements
Footnotes
References
  • 1. Beer R, Pfausler B, Schmutzhard E. Infectious intracranial complications in the neuro-ICU patient population. Curr Opin Crit Care. 2010;16(2):117-22. doi: 10.1097/MCC.0b013e328338cb5f. [PubMed: 20305552].
  • 2. Dashti SR, Baharvahdat H, Spetzler RF, Sauvageau E, Chang SW, Stiefel MF, et al. Operative intracranial infection following craniotomy. Neurosurg Focus. 2008;24(6):10. doi: 10.3171/FOC/2008/24/6/E10. [PubMed: 18518740].
  • 3. Jimenez CM, Polo J, Espana JA. Risk factors for intracranial infection secondary to penetrating craniocerebral gunshot wounds in civilian practice. World Neurosurg. 2013;79(5-6):749-55. doi: 10.1016/j.wneu.2012.06.025. [PubMed: 22722035].
  • 4. Yu Y, Li HJ. Diagnostic and prognostic value of procalcitonin for early intracranial infection after craniotomy. Braz J Med Biol Res. 2017;50(5):6021. doi: 10.1590/1414-431X20176021. [PubMed: 28443989].
  • 5. Lin C, Zhao X, Sun H. Analysis on the risk factors of intracranial infection secondary to traumatic brain injury. Chin J Traumatol. 2015;18(2):81-3. [PubMed: 26511298].
  • 6. Sturges BK, Dickinson PJ, Kortz GD, Berry WL, Vernau KM, Wisner ER, et al. Clinical signs, magnetic resonance imaging features, and outcome after surgical and medical treatment of otogenic intracranial infection in 11 cats and 4 dogs. J Vet Intern Med. 2006;20(3):648-56. [PubMed: 16734103].
  • 7. Chen K, Wu Y, Wang Q, Wang J, Li X, Zhao Z, et al. The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy. J Crit Care. 2015;30(1):218 e1-5. doi: 10.1016/j.jcrc.2014.09.020. [PubMed: 25449880].
  • 8. Fang YQ, Zhan RC, Jia W, Zhang BQ, Wang JJ. A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii. Medicine (Baltimore). 2017;96(31):7703. doi: 10.1097/MD.0000000000007703. [PubMed: 28767605].
  • 9. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VJ. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603-61. doi: 10.1128/CMR.00134-14. [PubMed: 26016486].
  • 10. Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, et al. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect. 2015;6:22-9. doi: 10.1016/j.nmni.2015.02.007. [PubMed: 26029375].
  • 11. van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med. 2010;362(2):146-54. doi: 10.1056/NEJMra0804573. [PubMed: 20071704].
  • 12. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39(6):776-82. doi: 10.1086/422997. [PubMed: 15472807].
  • 13. Ruan L, Wu D, Li X, Huang Q, Lin L, Lin J, et al. Analysis of microbial community composition and diversity in postoperative intracranial infection using highthroughput sequencing. Mol Med Rep. 2017;16(4):3938-46. doi: 10.3892/mmr.2017.7082. [PubMed: 29067467].
  • 14. Mashiko R, Taguchi S, Tobita T, Shibata Y. Intracranial infection caused by minor skin contusion associated with previous craniotomy. BMJ Case Rep. 2017;2017. doi: 10.1136/bcr-2016-217833. [PubMed: 28082307].
  • 15. Wei ZQ, Shen P, Chen YB, Xiao YH, Lan-Juan LI. Mohnarin report of 2011: distribution and drug resistance of the bacteria causing blood stream infections. Chinese J Nosocomiol. 2012;22(24):5493-502.
  • 16. Kumar A, Randhawa VS, Nirupam N, Rai Y, Saili A. Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India. J Infect Dev Ctries. 2014;8(8):1049-54. doi: 10.3855/jidc.4248. [PubMed: 25116673].
  • 17. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, et al. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 2010;15(46). [PubMed: 21144429].
  • 18. Kourbeti IS, Vakis AF, Ziakas P, Karabetsos D, Potolidis E, Christou S, et al. Infections in patients undergoing craniotomy: risk factors associated with post-craniotomy meningitis. J Neurosurg. 2015;122(5):1113-9. doi: 10.3171/2014.8.JNS132557. [PubMed: 25343179].
  • 19. Kessler AT, Kourtis AP. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid. Infection. 2007;35(4):271-4. doi: 10.1007/s15010-007-6211-z. [PubMed: 17646913].
  • 20. Lee DH, Palermo B, Chowdhury M. Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin. Clin Infect Dis. 2008;47(4):588-90. doi: 10.1086/590257. [PubMed: 18636964].
  • 21. Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G, et al. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. J Antimicrob Chemother. 2008;62 Suppl 1:i17-28. doi: 10.1093/jac/dkn250. [PubMed: 18684703].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments